stash
Posts:4

If the keytruda study clearly indicates the necessity of Pdl-1 receptors for adequate Pdl-1 response (7 VS 45%), is the genetic testing commercially available "before" enrolling in a clinical trial ? I seriously doubt that the manufacturers conducting the studies would reveal during the trial whether patients were responders or not.Thank you for your response. Stash

Discussion Topic
Full Archive

Reply # - June 13, 2015, 05:49 AM

JimC
Posts: 2753

Hi Stash,

Testing for PD-L1 is not really standardized, as each manufacturer has their own methods, so at this point patients are stuck with the test as it is performed for a particular trial. Dr. West has discussed this issue in this post, and there is a good discussion in this thread as well.

JimC
Forum moderator

Previous PostNext Post